Pelthos Therapeutics Inc. Insider Trading Update

TL;DR

Ezra Friedberg updated his Pelthos Therapeutics holdings on 4/2/26. Details pending.

AI Summary

On April 2, 2026, Ezra M. Friedberg reported a change in beneficial ownership of securities for Pelthos Therapeutics Inc. The filing details transactions related to his holdings, but specific details on the nature of the transactions, number of shares, or dollar amounts are not provided in this excerpt.

Why It Matters

Insider transactions can signal management's confidence or concerns about a company's future performance, potentially influencing investor decisions.

Risk Assessment

Risk Level: medium — Form 4 filings indicate insider activity, which can be a leading indicator of company performance, but the specific details of this transaction are not yet clear.

Key Numbers

• 2026-04-02 — Period of Report (Date of reported transaction)
• 2026-04-06 — Filing Date (Date the report was officially filed)

Key Players & Entities

• Ezra M. Friedberg (person) — Reporting Person
• Pelthos Therapeutics Inc. (company) — Issuer
• 0001919246 (company) — Issuer CIK
• 0001679440 (person) — Reporting Person CIK

FAQ

Key Financial Figures

• $20.30 — multiple trades at prices ranging from $20.30 to $20.78. The price reported in column
• $20.78 — trades at prices ranging from $20.30 to $20.78. The price reported in column 4 above r
• $21.31 — multiple trades at prices ranging from $21.31 to $22.03. The price reported in column
• $22.03 — trades at prices ranging from $21.31 to $22.03. The price reported in column 4 above r

Filing Documents

• wk-form4_1775509382.html (4)
• wk-form4_1775509382.xml (4) — 8KB
• 0001919246-26-000054.txt ( ) — 9KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). X Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Friedberg Ezra M (Last) (First) (Middle) C/O PELTHOS THERAPEUTICS INC. 4020 STIRRUP CREEK DRIVE, SUITE 110 (Street) DURHAM NORTH CAROLINA 27703 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol Pelthos Therapeutics Inc. [ PTHS ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 04/02/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 04/02/2026 S (1) 293 D $ 20.5121 (2) 82,292 D Common Stock 04/02/2026 S (1) 265 D $ 21.3612 (3) 82,027 D Common Stock 82,072 I By Balmoral Financial Group LLC (4) Common Stock 40,000 I By Key Recovery Group LLC (4) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer. 2. This transaction was executed in multiple trades at prices ranging from $20.30 to $20.78. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. 3. This transaction was executed in multiple trades at prices ranging from $21.31 to $22.03. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. 4. Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of this relationship, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein. Remarks: /s/ Francis Knuettel II, by power of attorney 04/06/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed b